Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
JOYFINAC-TOTAL is a multi-ingredient small molecule combination drug marketed by JoY Pharma, an Indian pharmaceutical company. It is positioned within the company's anti-allergic, cold, and cough therapeutic range. As a branded generic 'Total' cold formulation, it typically combines an analgesic and anti-inflammatory agent (Aceclofenac), an antipyretic (Paracetamol), a nasal decongestant (Phenylephrine), and an antihistamine (such as Cetirizine or Chlorpheniramine). The product is indicated for the symptomatic relief of the common cold, influenza, and allergic rhinitis, specifically targeting symptoms like nasal congestion, sneezing, headache, body aches, and fever. It is an approved, marketed product in India and is not an investigational drug in clinical development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on JOYFINAC-TOTAL.